Hmdb loader
Record Information
Version5.0
StatusDetected but not Quantified
Creation Date2012-09-06 21:02:59 UTC
Update Date2021-09-14 15:43:53 UTC
HMDB IDHMDB0028920
Secondary Accession Numbers
  • HMDB28920
Metabolite Identification
Common NameIsoleucyl-Valine
DescriptionIsoleucyl-Valine is a dipeptide composed of isoleucine and valine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an 'Expected' metabolite.
Structure
Data?1582753355
Synonyms
ValueSource
Ile-valMeSH
I-V dipeptideHMDB
Isoleucine valine dipeptideHMDB
Isoleucine-valine dipeptideHMDB
IsoleucylvalineHMDB
IV dipeptideHMDB
L-Isoleucyl-L-valineHMDB
2-[(2-Amino-1-hydroxy-3-methylpentylidene)amino]-3-methylbutanoateGenerator, HMDB
Chemical FormulaC11H22N2O3
Average Molecular Weight230.304
Monoisotopic Molecular Weight230.16304258
IUPAC Name2-(2-amino-3-methylpentanamido)-3-methylbutanoic acid
Traditional Name2-(2-amino-3-methylpentanamido)-3-methylbutanoic acid
CAS Registry NumberNot Available
SMILES
CCC(C)C(N)C(=O)NC(C(C)C)C(O)=O
InChI Identifier
InChI=1S/C11H22N2O3/c1-5-7(4)8(12)10(14)13-9(6(2)3)11(15)16/h6-9H,5,12H2,1-4H3,(H,13,14)(H,15,16)
InChI KeyBCXBIONYYJCSDF-UHFFFAOYSA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as dipeptides. These are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond.
KingdomOrganic compounds
Super ClassOrganic acids and derivatives
ClassCarboxylic acids and derivatives
Sub ClassAmino acids, peptides, and analogues
Direct ParentDipeptides
Alternative Parents
Substituents
  • Alpha-dipeptide
  • Isoleucine or derivatives
  • N-acyl-alpha-amino acid
  • Valine or derivatives
  • N-acyl-alpha amino acid or derivatives
  • Alpha-amino acid amide
  • Alpha-amino acid or derivatives
  • Branched fatty acid
  • Methyl-branched fatty acid
  • N-acyl-amine
  • Fatty amide
  • Fatty acid
  • Fatty acyl
  • Amino acid or derivatives
  • Secondary carboxylic acid amide
  • Carboxamide group
  • Amino acid
  • Carboxylic acid
  • Monocarboxylic acid or derivatives
  • Organic nitrogen compound
  • Organonitrogen compound
  • Primary aliphatic amine
  • Organooxygen compound
  • Primary amine
  • Hydrocarbon derivative
  • Carbonyl group
  • Organic oxide
  • Organopnictogen compound
  • Amine
  • Organic oxygen compound
  • Aliphatic acyclic compound
Molecular FrameworkAliphatic acyclic compounds
External DescriptorsNot Available
Ontology
Physiological effectNot Available
Disposition
ProcessNot Available
RoleNot Available
Physical Properties
StateSolid
Experimental Molecular Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogP-1.16Extrapolated
Experimental Chromatographic PropertiesNot Available
Predicted Molecular Properties
PropertyValueSource
Water Solubility9.89 g/LALOGPS
logP-1.1ALOGPS
logP-1.2ChemAxon
logS-1.4ALOGPS
pKa (Strongest Acidic)4.06ChemAxon
pKa (Strongest Basic)8.51ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count4ChemAxon
Hydrogen Donor Count3ChemAxon
Polar Surface Area92.42 ŲChemAxon
Rotatable Bond Count6ChemAxon
Refractivity60.39 m³·mol⁻¹ChemAxon
Polarizability25.15 ųChemAxon
Number of Rings0ChemAxon
BioavailabilityYesChemAxon
Rule of FiveYesChemAxon
Ghose FilterNoChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Predicted Chromatographic Properties

Predicted Collision Cross Sections

PredictorAdduct TypeCCS Value (Å2)Reference
DarkChem[M+H]+154.74631661259
DarkChem[M-H]-151.31531661259
DeepCCS[M+H]+155.630932474
DeepCCS[M-H]-153.24230932474
DeepCCS[M-2H]-187.65730932474
DeepCCS[M+Na]+163.5730932474
AllCCS[M+H]+154.532859911
AllCCS[M+H-H2O]+151.332859911
AllCCS[M+NH4]+157.532859911
AllCCS[M+Na]+158.432859911
AllCCS[M-H]-155.432859911
AllCCS[M+Na-2H]-156.632859911
AllCCS[M+HCOO]-157.932859911

Predicted Kovats Retention Indices

Underivatized

MetaboliteSMILESKovats RI ValueColumn TypeReference
Isoleucyl-ValineCCC(C)C(N)C(=O)NC(C(C)C)C(O)=O2738.4Standard polar33892256
Isoleucyl-ValineCCC(C)C(N)C(=O)NC(C(C)C)C(O)=O1710.9Standard non polar33892256
Isoleucyl-ValineCCC(C)C(N)C(=O)NC(C(C)C)C(O)=O1732.6Semi standard non polar33892256

Derivatized

Derivative Name / StructureSMILESKovats RI ValueColumn TypeReference
Isoleucyl-Valine,1TMS,isomer #1CCC(C)C(N)C(=O)NC(C(=O)O[Si](C)(C)C)C(C)C1801.0Semi standard non polar33892256
Isoleucyl-Valine,1TMS,isomer #2CCC(C)C(N[Si](C)(C)C)C(=O)NC(C(=O)O)C(C)C1836.5Semi standard non polar33892256
Isoleucyl-Valine,1TMS,isomer #3CCC(C)C(N)C(=O)N(C(C(=O)O)C(C)C)[Si](C)(C)C1814.7Semi standard non polar33892256
Isoleucyl-Valine,2TMS,isomer #1CCC(C)C(N[Si](C)(C)C)C(=O)NC(C(=O)O[Si](C)(C)C)C(C)C1868.4Semi standard non polar33892256
Isoleucyl-Valine,2TMS,isomer #1CCC(C)C(N[Si](C)(C)C)C(=O)NC(C(=O)O[Si](C)(C)C)C(C)C1830.4Standard non polar33892256
Isoleucyl-Valine,2TMS,isomer #2CCC(C)C(N)C(=O)N(C(C(=O)O[Si](C)(C)C)C(C)C)[Si](C)(C)C1808.8Semi standard non polar33892256
Isoleucyl-Valine,2TMS,isomer #2CCC(C)C(N)C(=O)N(C(C(=O)O[Si](C)(C)C)C(C)C)[Si](C)(C)C1862.2Standard non polar33892256
Isoleucyl-Valine,2TMS,isomer #3CCC(C)C(C(=O)NC(C(=O)O)C(C)C)N([Si](C)(C)C)[Si](C)(C)C2008.6Semi standard non polar33892256
Isoleucyl-Valine,2TMS,isomer #3CCC(C)C(C(=O)NC(C(=O)O)C(C)C)N([Si](C)(C)C)[Si](C)(C)C1873.2Standard non polar33892256
Isoleucyl-Valine,2TMS,isomer #4CCC(C)C(N[Si](C)(C)C)C(=O)N(C(C(=O)O)C(C)C)[Si](C)(C)C1888.3Semi standard non polar33892256
Isoleucyl-Valine,2TMS,isomer #4CCC(C)C(N[Si](C)(C)C)C(=O)N(C(C(=O)O)C(C)C)[Si](C)(C)C1851.6Standard non polar33892256
Isoleucyl-Valine,3TMS,isomer #1CCC(C)C(C(=O)NC(C(=O)O[Si](C)(C)C)C(C)C)N([Si](C)(C)C)[Si](C)(C)C2020.1Semi standard non polar33892256
Isoleucyl-Valine,3TMS,isomer #1CCC(C)C(C(=O)NC(C(=O)O[Si](C)(C)C)C(C)C)N([Si](C)(C)C)[Si](C)(C)C1958.6Standard non polar33892256
Isoleucyl-Valine,3TMS,isomer #2CCC(C)C(N[Si](C)(C)C)C(=O)N(C(C(=O)O[Si](C)(C)C)C(C)C)[Si](C)(C)C1902.1Semi standard non polar33892256
Isoleucyl-Valine,3TMS,isomer #2CCC(C)C(N[Si](C)(C)C)C(=O)N(C(C(=O)O[Si](C)(C)C)C(C)C)[Si](C)(C)C1927.7Standard non polar33892256
Isoleucyl-Valine,3TMS,isomer #3CCC(C)C(C(=O)N(C(C(=O)O)C(C)C)[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C2035.2Semi standard non polar33892256
Isoleucyl-Valine,3TMS,isomer #3CCC(C)C(C(=O)N(C(C(=O)O)C(C)C)[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C1977.0Standard non polar33892256
Isoleucyl-Valine,4TMS,isomer #1CCC(C)C(C(=O)N(C(C(=O)O[Si](C)(C)C)C(C)C)[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C2086.9Semi standard non polar33892256
Isoleucyl-Valine,4TMS,isomer #1CCC(C)C(C(=O)N(C(C(=O)O[Si](C)(C)C)C(C)C)[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C2058.4Standard non polar33892256
Isoleucyl-Valine,1TBDMS,isomer #1CCC(C)C(N)C(=O)NC(C(=O)O[Si](C)(C)C(C)(C)C)C(C)C2034.4Semi standard non polar33892256
Isoleucyl-Valine,1TBDMS,isomer #2CCC(C)C(N[Si](C)(C)C(C)(C)C)C(=O)NC(C(=O)O)C(C)C2077.8Semi standard non polar33892256
Isoleucyl-Valine,1TBDMS,isomer #3CCC(C)C(N)C(=O)N(C(C(=O)O)C(C)C)[Si](C)(C)C(C)(C)C2026.3Semi standard non polar33892256
Isoleucyl-Valine,2TBDMS,isomer #1CCC(C)C(N[Si](C)(C)C(C)(C)C)C(=O)NC(C(=O)O[Si](C)(C)C(C)(C)C)C(C)C2297.1Semi standard non polar33892256
Isoleucyl-Valine,2TBDMS,isomer #1CCC(C)C(N[Si](C)(C)C(C)(C)C)C(=O)NC(C(=O)O[Si](C)(C)C(C)(C)C)C(C)C2225.3Standard non polar33892256
Isoleucyl-Valine,2TBDMS,isomer #2CCC(C)C(N)C(=O)N(C(C(=O)O[Si](C)(C)C(C)(C)C)C(C)C)[Si](C)(C)C(C)(C)C2249.1Semi standard non polar33892256
Isoleucyl-Valine,2TBDMS,isomer #2CCC(C)C(N)C(=O)N(C(C(=O)O[Si](C)(C)C(C)(C)C)C(C)C)[Si](C)(C)C(C)(C)C2254.7Standard non polar33892256
Isoleucyl-Valine,2TBDMS,isomer #3CCC(C)C(C(=O)NC(C(=O)O)C(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C2424.6Semi standard non polar33892256
Isoleucyl-Valine,2TBDMS,isomer #3CCC(C)C(C(=O)NC(C(=O)O)C(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C2235.3Standard non polar33892256
Isoleucyl-Valine,2TBDMS,isomer #4CCC(C)C(N[Si](C)(C)C(C)(C)C)C(=O)N(C(C(=O)O)C(C)C)[Si](C)(C)C(C)(C)C2332.4Semi standard non polar33892256
Isoleucyl-Valine,2TBDMS,isomer #4CCC(C)C(N[Si](C)(C)C(C)(C)C)C(=O)N(C(C(=O)O)C(C)C)[Si](C)(C)C(C)(C)C2207.4Standard non polar33892256
Isoleucyl-Valine,3TBDMS,isomer #1CCC(C)C(C(=O)NC(C(=O)O[Si](C)(C)C(C)(C)C)C(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C2639.2Semi standard non polar33892256
Isoleucyl-Valine,3TBDMS,isomer #1CCC(C)C(C(=O)NC(C(=O)O[Si](C)(C)C(C)(C)C)C(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C2490.7Standard non polar33892256
Isoleucyl-Valine,3TBDMS,isomer #2CCC(C)C(N[Si](C)(C)C(C)(C)C)C(=O)N(C(C(=O)O[Si](C)(C)C(C)(C)C)C(C)C)[Si](C)(C)C(C)(C)C2530.6Semi standard non polar33892256
Isoleucyl-Valine,3TBDMS,isomer #2CCC(C)C(N[Si](C)(C)C(C)(C)C)C(=O)N(C(C(=O)O[Si](C)(C)C(C)(C)C)C(C)C)[Si](C)(C)C(C)(C)C2463.9Standard non polar33892256
Isoleucyl-Valine,3TBDMS,isomer #3CCC(C)C(C(=O)N(C(C(=O)O)C(C)C)[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C2670.4Semi standard non polar33892256
Isoleucyl-Valine,3TBDMS,isomer #3CCC(C)C(C(=O)N(C(C(=O)O)C(C)C)[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C2491.7Standard non polar33892256
Isoleucyl-Valine,4TBDMS,isomer #1CCC(C)C(C(=O)N(C(C(=O)O[Si](C)(C)C(C)(C)C)C(C)C)[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C2955.6Semi standard non polar33892256
Isoleucyl-Valine,4TBDMS,isomer #1CCC(C)C(C(=O)N(C(C(=O)O[Si](C)(C)C(C)(C)C)C(C)C)[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C2751.9Standard non polar33892256
Spectra

GC-MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted GC-MSPredicted GC-MS Spectrum - Isoleucyl-Valine GC-MS (Non-derivatized) - 70eV, Positivesplash10-052o-9400000000-efe15d5275cf31090b7b2017-09-01Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Isoleucyl-Valine GC-MS (1 TMS) - 70eV, Positivesplash10-0pic-9730000000-d9ecaffdf555cd9f73f12017-10-06Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Isoleucyl-Valine GC-MS (Non-derivatized) - 70eV, PositiveNot Available2021-10-12Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Isoleucyl-Valine GC-MS (Non-derivatized) - 70eV, PositiveNot Available2021-10-12Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Isoleucyl-Valine GC-MS (TMS_1_2) - 70eV, PositiveNot Available2021-11-04Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Isoleucyl-Valine GC-MS (TMS_1_3) - 70eV, PositiveNot Available2021-11-04Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Isoleucyl-Valine GC-MS (TBDMS_1_1) - 70eV, PositiveNot Available2021-11-04Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Isoleucyl-Valine GC-MS (TBDMS_1_2) - 70eV, PositiveNot Available2021-11-04Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Isoleucyl-Valine GC-MS (TBDMS_1_3) - 70eV, PositiveNot Available2021-11-04Wishart LabView Spectrum

MS/MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Experimental LC-MS/MSLC-MS/MS Spectrum - Isoleucyl-Valine 6V, Positive-QTOFsplash10-0019-9260000000-27e81bfaed5a9e7f4c722021-09-20HMDB team, MONAView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Isoleucyl-Valine 10V, Positive-QTOFsplash10-01q0-7590000000-736d93f1426d0ddb55ea2017-09-01Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Isoleucyl-Valine 20V, Positive-QTOFsplash10-00ri-9100000000-ce220530b238ea1808802017-09-01Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Isoleucyl-Valine 40V, Positive-QTOFsplash10-0avi-9000000000-340554d2b042369144432017-09-01Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Isoleucyl-Valine 10V, Negative-QTOFsplash10-004i-0590000000-84a49c1cc079a4b47d982017-09-01Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Isoleucyl-Valine 20V, Negative-QTOFsplash10-02dr-3940000000-dae68924c63485d701d02017-09-01Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Isoleucyl-Valine 40V, Negative-QTOFsplash10-0601-9300000000-8dbb2a3225610f75fc622017-09-01Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Isoleucyl-Valine 10V, Positive-QTOFsplash10-001i-1290000000-a9363763be2d1e94aa242021-09-22Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Isoleucyl-Valine 20V, Positive-QTOFsplash10-000i-9200000000-0b50185cb7e6cc1d45342021-09-22Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Isoleucyl-Valine 40V, Positive-QTOFsplash10-05fr-9000000000-831d2489e7198d5d0c8c2021-09-22Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Isoleucyl-Valine 10V, Negative-QTOFsplash10-03fr-0490000000-906732988992c48c1fec2021-09-23Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Isoleucyl-Valine 20V, Negative-QTOFsplash10-014i-2920000000-0952e836a2a4ec5fa8e32021-09-23Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Isoleucyl-Valine 40V, Negative-QTOFsplash10-052f-9200000000-d58f88caead55b2d87802021-09-23Wishart LabView Spectrum

NMR Spectra

Spectrum TypeDescriptionDeposition DateSourceView
Predicted 1D NMR13C NMR Spectrum (1D, 100 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 100 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 1000 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 1000 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 200 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 200 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 300 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 300 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 400 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 400 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 500 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 500 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 600 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 600 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 700 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 700 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 800 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 800 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 900 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 900 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Biological Properties
Cellular LocationsNot Available
Biospecimen Locations
  • Feces
Tissue LocationsNot Available
Pathways
Normal Concentrations
BiospecimenStatusValueAgeSexConditionReferenceDetails
FecesDetected but not QuantifiedNot QuantifiedAdult (>18 years old)Both
Normal
details
Abnormal Concentrations
BiospecimenStatusValueAgeSexConditionReferenceDetails
FecesDetected but not QuantifiedNot QuantifiedAdult (>18 years old)BothColorectal Cancer details
FecesDetected but not QuantifiedNot QuantifiedAdult (>18 years old)Both
Colorectal cancer
details
FecesDetected but not QuantifiedNot QuantifiedAdult (>18 years old)Both
Colorectal cancer
details
Associated Disorders and Diseases
Disease References
Colorectal cancer
  1. Brown DG, Rao S, Weir TL, O'Malia J, Bazan M, Brown RJ, Ryan EP: Metabolomics and metabolic pathway networks from human colorectal cancers, adjacent mucosa, and stool. Cancer Metab. 2016 Jun 6;4:11. doi: 10.1186/s40170-016-0151-y. eCollection 2016. [PubMed:27275383 ]
  2. Sinha R, Ahn J, Sampson JN, Shi J, Yu G, Xiong X, Hayes RB, Goedert JJ: Fecal Microbiota, Fecal Metabolome, and Colorectal Cancer Interrelations. PLoS One. 2016 Mar 25;11(3):e0152126. doi: 10.1371/journal.pone.0152126. eCollection 2016. [PubMed:27015276 ]
  3. Goedert JJ, Sampson JN, Moore SC, Xiao Q, Xiong X, Hayes RB, Ahn J, Shi J, Sinha R: Fecal metabolomics: assay performance and association with colorectal cancer. Carcinogenesis. 2014 Sep;35(9):2089-96. doi: 10.1093/carcin/bgu131. Epub 2014 Jul 18. [PubMed:25037050 ]
Associated OMIM IDs
DrugBank IDNot Available
Phenol Explorer Compound IDNot Available
FooDB IDFDB111948
KNApSAcK IDNot Available
Chemspider ID385545
KEGG Compound IDNot Available
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkNot Available
METLIN IDNot Available
PubChem Compound435949
PDB IDNot Available
ChEBI IDNot Available
Food Biomarker OntologyNot Available
VMH IDNot Available
MarkerDB IDNot Available
Good Scents IDNot Available
References
Synthesis ReferenceNot Available
Material Safety Data Sheet (MSDS)Not Available
General References
  1. Suh YJ, Kim BM, Park BH, Park H, Kim YJ, Kim H, Hong YC, Ha EH: Cytochrome P450IA1 polymorphisms along with PM(10) exposure contribute to the risk of birth weight reduction. Reprod Toxicol. 2007 Nov-Dec;24(3-4):281-8. Epub 2007 Jul 7. [PubMed:17706398 ]
  2. CHEN PF, MALLETTE MF: SYNTHESIS OF THE NEW DIPEPTIDE ISOLEUCYLVALINE BY AN IMPROVEMENT OF METHODS APPLIED TO ALIPHATIC AMINO ACIDS. Nature. 1964 May 9;202:598-9. [PubMed:14195067 ]
  3. Kammerer S, Burns-Hamuro LL, Ma Y, Hamon SC, Canaves JM, Shi MM, Nelson MR, Sing CF, Cantor CR, Taylor SS, Braun A: Amino acid variant in the kinase binding domain of dual-specific A kinase-anchoring protein 2: a disease susceptibility polymorphism. Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):4066-71. Epub 2003 Mar 19. [PubMed:12646697 ]
  4. Wang JJ, Zheng Y, Sun L, Wang L, Yu PB, Li HL, Tian XP, Dong JH, Zhang L, Xu J, Shi W, Ma TY: CYP1A1 Ile462Val polymorphism and susceptibility to lung cancer: a meta-analysis based on 32 studies. Eur J Cancer Prev. 2011 Nov;20(6):445-52. doi: 10.1097/CEJ.0b013e328345f937. [PubMed:22025136 ]
  5. Bulaj G, Otlewski J: Ligand-induced changes in the conformational stability of bovine trypsinogen and their implications for the protein function. J Mol Biol. 1995 Apr 7;247(4):701-16. [PubMed:7723025 ]